SPRAVATOTM
SPRAVATO™, also known as esketamine, is a nasal spray that rapidly alleviates depressive symptoms and when used in conjunction with therapy, assists in rapid healing of treatment-resistant depression and other mood disorders. The approval of this drug by the FDA is considered to be one of the most significant advances in mental health in the last 30 years, as now patients who have failed 2 or more antidepressants have a safe, fast-acting, solution that is covered by insurance.
